Abstract: Pancreatic ductal adenocarcinomas (PDACs) are highly metastatic with poor prognosis, mainly due to delayed detection. We hypothesized that intercellular communication is critical for metastatic progression.
By Amanda Gordon (Bloomberg Business) – Cancer biologist Christine Mayr found common ground Thursday night with Bill Ackman.
By Ransdell Pierson (Reuters) – New therapies that clinical data show can eliminate blood cancers such as leukemia and lymphoma in 40 percent to 90 percent of patients may have to be genetically modified to include a switch that shields healthy cells from attack.
By Caroline Lewis (Crain’s New York Business) – The Pershing Square Sohn Cancer Research Alliance will announce Thursday the second class of early-career cancer researchers to win funding and support through its program.
The Pershing Square Sohn Prize winners are making bold advances in research for leukemia, lymphoma, melanoma, pancreatic, prostate, skin, lung, and breast cancer
By Sabrina Tavernise (The New York Times) – In a letter to colleagues announcing his departure as the director of the National Cancer Institute, Dr. Harold Varmus, 75, quoted Mae West. “I’ve been rich and I’ve been poor,” he wrote, “and rich is better.”
By Bernard Meyerson (Scientific American) From autonomous drones to emergent AI to digital genomes, this year’s list from the World Economic Forum offers its latest glimpse of our fast-approaching technological future
By Gina Kolata (The New York Times) – Chemotherapy and radiation failed to thwart Erika Hurwitz’s rare cancer of white blood cells. So her doctors offered her another option, a drug for melanoma. The result was astonishing.
By Gina Kolata (The New York Times) – More than 200 scientists working on an ambitious federal project have begun to understand the complicated system of switches that regulates genes, turning some on and others off, making some glow brightly while others dim.
By Michael S. Malone (The Wall Street Journal) – The National Academy of Sciences warned a decade ago that young scientists in biomedicine were struggling to launch careers for lack of research money. A NAS report released in January says the situation has grown more “arresting” in all fields: